Prosidyan® develops proprietary fiber-based bioactive glass products

The company was founded in 2009 in Warren, New Jersey, USA to develop a family of synthetic bioactive bone graft substitutes based on microscopic fibers of bioactive glass. The Chief Executive Officer of the company is Charanpreet Bagga, best known as “CB”, recognized as a highly accomplished industry leader for his development of innovative medical devices with over 100+ patents and patent filings to his credit.